Zeng Li
Impact in
- Nephrology top 10%
- Acute Kidney Injury Research
- Pharmacology top 10%
- Cholinesterase and Neurodegenerative Diseases
Papers in
-
- Phenothiazines and Benzothiazines Synthesis and Activities 4
- Pharmacology 14
- Cholinesterase and Neurodegenerative Diseases 12
- Co-authors
- Mingfei Wu (7 shared papers)Xiao‐Ming Meng (8 shared papers)Cheng Huang (4 shared papers)Min Wang (3 shared papers)Hai-Di Li (4 shared papers)Taotao Ma (3 shared papers)Xingyi Li (2 shared papers)Jun Li (4 shared papers)
- Journals
- European Journal of Medicinal Chemistry (9 papers)Chemico-Biological Interactions (5 papers)Molecules (4 papers)International Immunopharmacology (4 papers)Bioorganic Chemistry (3 papers)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Zeng Li
78 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 113
- Nephrology 81
- Pharmacology 168
- Computational Theory and Mathematics 154
- Pharmacology 63
- Organic Chemistry 192
Countries citing papers authored by Zeng Li
This map shows the geographic impact of Zeng Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zeng Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zeng Li more than expected).
Fields of papers citing papers by Zeng Li
This network shows the impact of papers produced by Zeng Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zeng Li. The network helps show where Zeng Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Zeng Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 83 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 79 | |
| 2 | 2020 | 73 | |
| 3 | 2023 | 53 | |
| 4 | 2011 | 47 | |
| 5 | 2020 | 45 | |
| 6 | 2011 | 44 | |
| 7 | Development of new multivalent-bispecific agents for pretargeting tumor localization and therapy. | 2003 | 43 |
| 8 | 2021 | 40 | |
| 9 | 2017 | 32 | |
| 10 | 2017 | 31 | |
| 11 | 2016 | 30 | |
| 12 | 2021 | 27 | |
| 13 | 2020 | 27 | |
| 14 | 2019 | 27 | |
| 15 | 2012 | 26 | |
| 16 | 2014 | 24 | |
| 17 | 2022 | 24 | |
| 18 | 2022 | 24 | |
| 19 | 2020 | 22 | |
| 20 | 2014 | 20 |
About Zeng Li
Zeng Li is a scholar working on Molecular Biology, Pharmacology, Organic Chemistry, Computational Theory and Mathematics and Immunology, having authored 83 papers that have together received 1.1k indexed citations. Recurring topics across this work include Computational Drug Discovery Methods (12 papers), Cholinesterase and Neurodegenerative Diseases (12 papers), Quinazolinone synthesis and applications (6 papers), Alzheimer's disease research and treatments (5 papers), Phenothiazines and Benzothiazines Synthesis and Activities (4 papers), Acute Kidney Injury Research (4 papers), Peptidase Inhibition and Analysis (4 papers) and Alcohol Consumption and Health Effects (4 papers). The work is most often cited by research in Nephrology (81 citations), Pharmacology (168 citations), Computational Theory and Mathematics (154 citations), Pharmacology (63 citations) and Organic Chemistry (192 citations). Zeng Li has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Mingfei Wu, Xiao‐Ming Meng, Cheng Huang, Min Wang, Hai-Di Li, Taotao Ma, Xingyi Li, Jun Li, Shuai Shi and Tao Xu. Their work appears in journals such as European Journal of Medicinal Chemistry, Chemico-Biological Interactions, Molecules, International Immunopharmacology and Bioorganic Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.